
Taxifa S 1.5gm Injection
Marketer
Intas Pharmaceuticals Ltd
Salt Composition
Cefotaxime (1.5gm)
Overview Taxifa S 1.5gm Injection
Cefixime 1.5g Injection is an antibacterial medication combating various bacterial infections. Its efficacy extends to infections affecting the brain, lungs, ears, urinary tract, skin, soft tissues, bones, joints, bloodstream, and heart. Prophylactic use is also indicated before surgical procedures. This injection inhibits bacterial proliferation, alleviating symptoms and resolving the underlying infection. Administered intravenously or intramuscularly by a healthcare professional, dosage is determined by your physician. Adherence to the prescribed schedule, with evenly spaced doses, is crucial. Premature cessation may result in infection recurrence or exacerbation. Common side effects include skin rash and diarrhea; localized redness or pain at the injection site may also occur temporarily. These typically subside, but persistent or bothersome effects necessitate medical consultation. Prior to use, inform your doctor of any antibiotic allergies, liver or kidney issues, and all other medications you are currently using. Pregnant or breastfeeding individuals should seek medical advice before commencing treatment.
Primary Ingredients of Taxifa S 1.5gm Injection
No text provided. Please provide the text you would like me to rephrase.
Uses of Taxifa S 1.5gm Injection
Managing bacterial infections
Major Benefits of Taxifa S 1.5gm Injection:
This medication will be administered by your healthcare provider; self-medication is strictly prohibited.
Common Side effects of Taxifa S 1.5gm Injection:
- Injection site reactions (pain, swelling, redness)
- Hypersensitivity
- Gastrointestinal disorder
How to use Taxifa S 1.5gm Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Taxifa S 1.5gm Injection works:
Taxifa S 1.5gm Injection is a bactericidal antibiotic that works by disrupting bacterial cell wall synthesis, a process essential for bacterial viability.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of Taxifa S 1.5gm Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Administration of Taxifa S 1.5gm Injection during gestation is typically deemed safe. Preclinical trials in animals revealed minimal or absent negative consequences for fetal development; nevertheless, clinical data from human subjects are scarce.
Breast feedingSAFE IF PRESCRIBED
Taxifa S 1.5gm Injection presents minimal risk during lactation. Research in humans indicates negligible transfer to breast milk, posing no apparent threat to the infant. However, extended use of Taxifa S 1.5gm Injection should be avoided due to potential side effects including skin rashes and loose stools.
DrivingUNSAFE
Administering Taxifa S 1.5gm Injection might cause drowsiness, blurred vision, or dizziness. Driving should be avoided if these effects are experienced.
KidneyCAUTION
Patients with kidney impairment should use Taxifa S 1.5gm Injection cautiously, as dose modification may be necessary. Physician consultation is recommended. Routine monitoring of renal function is advisable during treatment.
LiverSAFE IF PRESCRIBED
Taxifa S 1.5gm Injection poses no safety concerns for patients with hepatic impairment; dosage modification is unnecessary.
What if you forget to take Taxifa S 1.5gm Injection :
Omit a Taxifa S 1.5gm Injection dose? Seek your physician's advice.
Facts to Know About Taxifa S 1.5gm Injection
| Label | Value |
|---|---|
| Chemical Category | Extended-Spectrum Cephalosporins (Generations 3 & 4) |
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
| Behavior Class | Third-generation Cephalosporins |
